The recent rise for Catalent can be attributed to reports of Danaher looking to acquire the company. Catalent’s revenue growth over the recent years was primarily driven by robust demand for its ...
It's unclear how Catalent will proceed or whether it's receptive to a takeover offer, Bloomberg reported citing people familiar with the matter. Danaher and Catalent deal could be one of the ...
Danaher's approach to Catalent values it at a significant premium, the report said, adding that unclear how Catalent will proceed or whether it is receptive to a takeover offer. A deal is not ...
So I found the recent news that Danaher is interested in acquiring contract manufacturer Catalent, Inc. (CTLT) quite interesting. Putting myself in the shoes of an investor who plans to buy shares ...
UKRAINE - 2021/05/04: In this Photo illustration a Catalent logo of a pharmaceutical company is seen ... [+] on a smartphone and a pc screen. (Photo Illustration by Pavlo Gonchar/SOPA Images ...
Pall Corp. (PLL) stock is rising after the company said it will be acquired by Danaher (DHR) for $13.8 billion. Pall Corp. (PLL) stock is rising after the company said it will be acquired by ...
Shares of Catalent (NYSE:CTLT) surged 24% in pre-open trading Monday following a report over the weekend from Bloomberg News that Danaher (NYSE:DHR) has expressed interest in acquiring the contract ...
(Bloomberg) -- Life sciences company Danaher Corp. has expressed takeover interest in contract manufacturer Catalent Inc., according to people familiar with the matter. Most Read from Bloomberg ...
Catalent, Inc. CTLT recently announced its successful formulation design and clinical-phase manufacturing collaboration with Grünenthal for an orally dosed small molecule in the latter’s pipeline.
